Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	3523.39	71.23	-1.97
Graham Fair Price	-90.49	11193.49	117674.99
PEG	3346298.99	0.02	< 0.005
Price/Book	14.21	-0.15	-0.18
Price/Cash Flow	-44.31	-0.43	-0.29
Prices/Earnings	-9914.80	-1.55	-0.02
Price/Sales	20.08	0.12	0.10
Price/FCF	-44.31	-0.43	-0.29
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	15.55	0.10	0.08
Operating Margin	-96.29	0.05	-1.41
ROA	99.15	< 0.005	-0.31
ROE	2.92	0.03	-99.14
ROIC	-0.59	0.02	-97.07
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	0.08	0.17	-53.74
Dividends QOQ	-1.00	-1.00	< 0.005
EBIT QOQ	-67.99	1.03	-98.49
EPS QOQ	-331.20	0.99	-99.70
FCF QOQ	-13.84	0.39	-97.19
Revenue QOQ	0.32	-0.27	-15.98
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	62.77	80.75	28.64
Days Sales Outstanding (DSO)	133.73	208.34	55.80
Inventory Turnover	1.43	1.11	-22.27
Debt/Capitalization	1.25	1.23	-1.19
Quick Ratio	0.43	0.44	2.14
Naive Interpretation	member

04 - Leverage & Liquidity · Bad

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	-14521.38	-14924.57	-2.78
Cash	13080.64	13453.58	2.85
Capex	61.17	-50.16	-18.00
Free Cash Flow	-8882.40	-5426.96	38.90
Revenue	25250.74	18540.44	-26.57
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	0.64	0.62	-3.03
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-1.89	69.05	3548.69
Naive Interpretation	Member

06 - Financial Health · Bad

Rating